EPCAM and ovarian cancer: Ascitic fluid from ovarian cancer patients has previously been reported to contain large amounts of EVs containing EpCAM [38, 39], and when 12 μl of ascites were tested by flow cytometry, EpCAM was successfully detected in all the ascitic fluid samples with high expression in several of them (Fig. 5C).